ep exclud amort intang asset acquisit charger transit cost bill adjust consolid cost oper
 estim adjust number new revenu recognit rule relat bad debt expens
headquart secaucu nj lead provid diagnost inform servic
access laboratori patient servic center compani gener revenu billion
cash earn per share pre-adjust quest divid busi two segment diagnost
inform servic diagnost solut
reason comment
februari quest report fourth quarter full-year result in-lin expect
compani guidanc fourth quarter revenu increas billion billion earn per share
increas revenu increas billion billion earn per share
increas pre-adjust fy revenu ep result quest provid overview
year outlin landscap
organ growth driven continu success non-invas prenat test nipt prescript drug
monitor tb hepat test focu turn precis oncolog profession lab
servic result stronger test mix sophist advanc diagnost
half quest patient servic center use check-in kiosk significantli
improv effici price continu less headwind quest continu form
partnership aetna secur contract potenti unit
compani provid guidanc revenu growth billion cash earn per
share growth revenu adjust new revenu recognit rule
relat bad debt adjust billion million less acquisit contribut
growth versu guid quest high-end top-line growth estim ep
exclud excess tax benefit stock compens adjust
respect notabl increas capital-expenditure approxim million versu million help fund
new laboratori new jersey consum growth strategi final buildout new secaucu headquart
quest provid clariti impact tax reform compani expect million after-tax save
million reinvest busi advanc diagnost consum experi
bonu non-exec employe million fall earn translat
benefit ep help off-set expect headwind medicar rate cut induc pama
manag also author quarterli dividend increas per share
estim quest gener revenu billion billion ebitda cash ep
quest commit long-term goal revenu growth mid-to-high-singl digit earn
growth despit new medicar rate effect save tax reform allow quest
exceed goal earn per share expect share count remain stabl compani
seek off-set option dilut
million except per share
compani data gabelli compani estim
quest diagnost continu grow top-lin specialti test hospit outreach acquisit
expand oper margin consist cost save program compani remain commit
long-term growth outlook grow revenu grow ep mid-to-high-singl digit estim
quest gener revenu billion ebitda billion earn per share quest
embodi strength industri lead share billion us clinic lab market believ
continu expand creat valu valu quest ebitda calcul pmv per share
recommend investor hold share
million except per share
current market discount pmv
after-tax payment buy option holder privat market valu
compani data gabelli compani estim
sara wojda research analyst prepar report herebi certifi view express report accur reflect analyst person
view subject compani secur research analyst receiv direct indirect compens
express specif recommend view report
public data may rate hold
